180 Life Sciences Corp. Files 8-K for Material Agreement
Ticker: FRMM · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action, pharmaceuticals
Related Tickers: ATNF
TL;DR
180 Life Sciences Corp. signed a big deal on 4/28/25. 8-K filed.
AI Summary
On April 28, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations industry. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant development for 180 Life Sciences Corp., potentially involving a new contract, partnership, or acquisition that could impact its business operations and future prospects.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided header information.
Key Numbers
- 001-38105 — Commission File Number (SEC File Number for 180 Life Sciences Corp.)
- 90-1890354 — IRS Employer Identification No. (Tax Identification for 180 Life Sciences Corp.)
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former Company Name
- April 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 3000 El Camino Real (address) — Business Address
FAQ
What type of material definitive agreement did 180 Life Sciences Corp. enter into?
The provided header information for the 8-K filing indicates an 'Entry into a Material Definitive Agreement' as an item information, but the specific details of the agreement are not included in this section.
When was 180 Life Sciences Corp. formerly known as KBL Merger Corp. IV?
The date of the name change from KBL Merger Corp. IV to 180 Life Sciences Corp. was November 15, 2016.
What is the primary business of 180 Life Sciences Corp. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where is 180 Life Sciences Corp. incorporated?
180 Life Sciences Corp. is incorporated in Delaware.
What is the fiscal year end for 180 Life Sciences Corp.?
The fiscal year end for 180 Life Sciences Corp. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding 180 Life Sciences Corp. (FRMM).